相关实验视频
Updated: May 10, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.2K
通过miRNA-485-5p调节RASD2驱动甲状腺癌的进展和转移
Xiao-Yu Li1, Jian-Ping Sun2, Hao Guo1
1Department of Thyroid and Breast Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
The Kaohsiung journal of medical sciences
|April 28, 2025
概括
在甲状腺癌中,Ras Homolog Enriched In Striatum (RASD2) 的高调,促进瘤的进展和转移. 通过microRNA-485-5p调节的RASD2抑制,显示了对甲状腺癌的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 甲状腺癌是一个重要的健康问题,具有复杂的进展机制.
- 确定关键的分子驱动因素和调节途径对于有效的治疗策略至关重要.
研究的目的:
- 调查Ras Homolog Enriched In Striatum (RASD2) 在甲状腺癌进展中的作用.
- 为了阐明RASD2和microRNA-485-5p之间的调节关系.
- 评估针对甲状腺癌中RASD2途径的治疗潜力.
主要方法:
- 公共数据库和临床标本的生物信息分析.
- 免疫组织化学和qRT-PCR用于基因表达验证.
- 在体外功能测定 (增殖,侵入,糖解) 和体内异种移植/转移模型.
- 分子研究以确认miRNA-目标相互作用.
主要成果:
- 在甲状腺癌中,RASD2显著上调,与晚期,转移和入侵相关.
- 在甲状腺癌细胞中抑制RASD2的扩散,入侵和糖解.
- 微RNA-485-5p作为RASD2的负调节剂,表现出瘤抑制作用.
- 抑制RASD2可以减少瘤生长和体内转移.
结论:
- 微RNA-485-5p/RASD2轴是甲状腺癌中关键的调节途径.
- RASD2是甲状腺癌的潜在治疗点.
- 这项研究为甲状腺癌的发病和治疗提供了新的见解.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
MicroRNAs
21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

